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Modifications in histologically normal tissue distal to
tumours are increasingly evident and the role of such
molecular events in tumour susceptibility or in response
to presence of a tumour is unclear. We have exploited
the ability to explain distal tissue modifications in the
dab fish (Limanda limanda) which has an unprecedented
high occurrence of hepatic adenoma (up to 20%) when
analysed from the natural environment. To investigate
this, three tissue categories of hepatocellular adenoma,
histologically normal liver tissue distal to tumours and
livers of non-tumour-bearing dab were used. A multi-
“omics” approach was used to provide a comprehensive
understanding of the key molecular abnormalities. A
remarkable and consistent global hypomethylation, modi-
fication of CpG island methylation, gene expression and
disruption of one-carbon metabolism was discovered in
normal tissue distal to tumours compared to livers of
non-tumour-bearing fish. The mechanism of this disrup-
tion is linked, not to depletion of S-adenosylmethionine,
as is often a feature of mammalian tumours, but to a
decrease in choline and elevated S-adenosylhomocysteine,
a potent inhibitor of DNA methytransferase. This novel
feature of normal-appearing tissue of tumour-bearing fish
helps to understand the unprecedentedly high incidence
of tumours in fish sampled from the field and adds
weight to the controversial epigenetic progenitor model
of tumourigenesis.
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